Corcept Therap(CORT.US)

Event Tracking

Jan9

Corcept Therapeutics' Chief Development Officer Disposes of Common Stock

01:36

Dec31

Wolfe Research Downgrades Corcept Therapeutics Rating

15:04

Corcept Therapeutics drug application rejected by FDA

13:04

Dec30

Corcept Therapeutics' Chief Commercial Officer Exercises 145,000 Share Options

15:02

Dec22

Corcept Therapeutics' Relacorilant Awaits FDA Approval

16:57

Dec4

Corcept Therapeutics Inc Executives Sean Maduck Sold $1.6 Million in Stocks

02:02

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 207.64 M, Net Income 19.36 M, EPS 0.16

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 194.43 M, Net Income 34.61 M, EPS 0.29

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 157.21 M, Net Income 20.29 M, EPS 0.17

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change